BACKGROUND: The role of laterality for patients with synchronous metastatic colon cancer (SMCC) is not well-defined. METHODS: Using the National Cancer Database (2010-2015), we compared patients with metastatic right- (RCC) versus left-sided colon cancer (LCC). We performed Kaplan-Meier analysis to compare overall survival (OS) for each metastatic site and utilized adjusted Cox proportional hazard analysis to identify predictors of OS. RESULTS: Patients with RCCs were more likely to be older, female, and have more comorbidities. LCCs were more likely to metastasize to liver and lung, whereas RCCs were more likely to metastasize to peritoneum and brain. There was equal likelihood to metastasize to bone. OS was significantly longer for LCCs for all metastatic sites. After controlling for multiple variables, RCC (HR 1.426, p < 0.001) remained an independent predictor of worse OS compared to LCC. CONCLUSIONS: Laterality of the primary tumor plays an important role in outcomes for patients with SMCC.
BACKGROUND: The role of laterality for patients with synchronous metastatic colon cancer (SMCC) is not well-defined. METHODS: Using the National Cancer Database (2010-2015), we compared patients with metastatic right- (RCC) versus left-sided colon cancer (LCC). We performed Kaplan-Meier analysis to compare overall survival (OS) for each metastatic site and utilized adjusted Cox proportional hazard analysis to identify predictors of OS. RESULTS:Patients with RCCs were more likely to be older, female, and have more comorbidities. LCCs were more likely to metastasize to liver and lung, whereas RCCs were more likely to metastasize to peritoneum and brain. There was equal likelihood to metastasize to bone. OS was significantly longer for LCCs for all metastatic sites. After controlling for multiple variables, RCC (HR 1.426, p < 0.001) remained an independent predictor of worse OS compared to LCC. CONCLUSIONS: Laterality of the primary tumor plays an important role in outcomes for patients with SMCC.
Authors: Scott Kopetz; George J Chang; Michael J Overman; Cathy Eng; Daniel J Sargent; David W Larson; Axel Grothey; Jean-Nicolas Vauthey; David M Nagorney; Robert R McWilliams Journal: J Clin Oncol Date: 2009-05-26 Impact factor: 44.544
Authors: Suguru Yamashita; Kristoffer Watten Brudvik; Scott E Kopetz; Dipen Maru; Callisia N Clarke; Guillaume Passot; Claudius Conrad; Yun Shin Chun; Thomas A Aloia; Jean-Nicolas Vauthey Journal: Ann Surg Date: 2018-03 Impact factor: 12.969
Authors: Taher Reza Kermanshahi; Deepa Magge; Haroon Choudry; Leksmi Ramalingam; Benjamin Zhu; James Pingpank; Steven Ahrendt; Matthew Holtzman; Herbert Zeh; David Bartlett; Amer Zureikat; Reetesh K Pai Journal: Int J Surg Pathol Date: 2016-09-24 Impact factor: 1.271
Authors: Steven S Shen; Bisong X Haupt; Jae Y Ro; Jijiang Zhu; H Randoph Bailey; Mary R Schwartz Journal: Arch Pathol Lab Med Date: 2009-05 Impact factor: 5.534
Authors: J H Park; T-Y Kim; K-H Lee; S-W Han; D-Y Oh; S-A Im; G H Kang; E K Chie; S W Ha; S-Y Jeong; K J Park; J-G Park; T-Y Kim Journal: Br J Cancer Date: 2013-03-12 Impact factor: 7.640